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VentilationComputed Tomography Ventilation Imaging (CTVI) is an experimental imaging modality that derives
regional lung function information from non-contrast respiratory-correlated CT datasets. Despite CTVI
being extensively studied in cross-modality imaging comparisons, there is a lack of consensus on the
state of its clinical validation in humans. This systematic review evaluates the CTVI clinical validation
studies to date, highlights their common strengths and weaknesses and makes recommendations. We
performed a PUBMED and EMBASE search of all English language papers on CTVI between 2000 and
2018. The results of these searches were filtered in accordance to a set of eligibility criteria and analysed
in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
Guidelines. One hundred and forty-four records were identified, and 66 full text records were reviewed.
After detailed assessment, twenty-three full text papers met the selection criteria and were included in
the final review. This included thirteen prospective studies, with 579 human subjects. Studies used
diverse methodologies, with a large amount of heterogeneity between different studies in terms of the
reference ventilation imaging modality (e.g. nuclear medicine, hyperpolarised gas MRI), imaging param-
eters, DIR algorithm(s) used, and ventilation metric(s) applied. The most common ventilation metrics
used deformable image registration to evaluate the exhale-to-inhale motion field Jacobian determinant
(DIR-Jac) or changes in air volume content based on Hounsfield Units (DIR-HU). The strength of correla-
tion between CTVI and the reference ventilation imaging modalities was moderate to strong when eval-
uated at the lobar or global level, with the average ± S.D. (number of studies) linear regression correlation
coefficients were 0.73 ± 0.25 (n = 6) and 0.86 ± 0.11 (n = 12) for DIR-Jac and DIR-HU respectively, and the
SPC were 0.45 ± 0.31 (n = 6) and 0.41 ± 0.11 (n = 5) for DIR-Jac and DIR-HU respectively. We concluded
that it is difficult to make a broad statement about the validity of CTVI due to the diverse methods used
in the validation literature. Typically, CTVI appears to show reasonable cross-modality correlations at the
lobar/whole lung level but poor correlations at the voxel level. Since CTVI is seeing new implementations
in prospective trials, it is clear that refinement and standardization of the clinical validation methodolo-
gies are required. CTVI appears to be of relevance in radiotherapy planning, particularly in patients whose
main pulmonary impairment is not a gas exchange problem but alternative imaging approaches may
need to be considered in patients with other pulmonary diseases (i.e. restrictive or gas exchange
problems).
 2019 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 137 (2019) 175–185The idea of deriving information about regional pulmonary func-
tion from respiratory-correlated computed tomography (CT), espe-cially 4-Dimensional Computed Tomography (4DCT) and inhale/
exhale breath-hold CT (BHCT), without exogenous contrast is highly
attractive. In the context of radiotherapy treatment planning,
respiratory-correlated thoracic CT scans are acquired routinely for
lung cancer patients, a population with significant impairment of
respiratory function, and breast cancer patients, where radiation-
Table 1
PICOS table for study question.
Patient/participants Human or animal subjects undergoing 4DCT or BHCT
Intervention Generation of CTVI
Comparison Accepted contrast-based imaging for regional lung
function, including c-scintigraphy, ventilation SPECT or
PET, Hyperpolarized gas MRI, single or dual energy CT
OR
Accepted pulmonary function tests for global lung
function, including spirometry and measurements for
static lung function parameters
Outcome Correlation of CTVI parameters (evaluated at the voxel,
sub-organ or whole-organ level) versus clinical
function (imaging or spirometry)
Study Retrospective or prospective study quantified animal
and human studies
176 Is CT Ventilation Imaging the Answer for Assessing Regional Ventilation?induced lung toxicity remains a major dose-limiting factor. CT Ven-
tilation Imaging (CTVI) is a method for visualizing regional air vol-
ume changes in the lung [1,2] combining 4DCT or BHCT scans with
deformable image registration (DIR) to visualize the breathing-
induced change in air volume, or ‘‘ventilation,” an important com-
ponent of blood–gas exchange. CTVI is currently the subject of a
number of clinical trials, which are integrating CTVI data into radio-
therapy planning [3,4] with the goal of minimizing irradiation of
functional lung and potentially minimizing pulmonary toxicity.
Attempts have been made to validate CTVI against a wide range
of clinical and experimental ventilation imaging modalities includ-
ing 99mTc-labelled diethylenetriamine pentaacetate (DTPA)
V-SPECT [4,5], 68Ga (Galligas) PET [6], 3He MRI [7], 129Xe MRI [8],
81m-Kr [9] and Technegas V-SPECT [10].
Almost all CTVI methods involve the application of DIR between
the 4DCT or BHCT exhale and inhale phase images, with the DIR
motion field then used to compute breathing-induced ventilation
‘‘metrics” at the voxel level. These are mainly based on regional
lung volume changes as quantified by the DIR motion field Jaco-
bian determinant (‘‘DIR-Jac” methods), or evaluation of air volume
changes as indicated by changes in the CT number or Hounsfield
Units (‘‘DIR-HU” methods). There are many sources of variation
for studies comparing CTVI to other lung function imaging includ-
ing: the CT acquisition protocol and breathing manoeuvre [11], the
type of DIR method used for evaluating lung motion, the type of
ventilation metric employed, the presence (or not) of image
pre/post processing, and the choice of metrics used to evaluate
the cross-modality correlation. Some of the most salient findings
are that the 4DCT or BHCT image quality can significantly impact
on CTVI generation [10]; DIR based metrics in particular, are highly
sensitive to image artefacts, which may impair the ability to gener-
ate accurate CTVI images in the presence of 4DCT motion artefacts
due to irregular breathing. There is also heterogeneity in the meth-
ods used to define ‘‘high function” or ‘‘low function” lung; some
studies apply semi-automated thresholding approaches, whereas
others perform a subjective clinical assessment of the image. The
use of different types of ‘‘reference” ventilation imaging modalities,
such as SPECT, PET, hyperpolarised gas MRI and Xenon-CT, intro-
duces an additional complexity in that all of these imaging modal-
ities operate on different (if complimentary) contrast mechanisms.
Similarly, the various published CTVI metrics (mainly, dealing with
lung volume or density change), are all related yet clearly distinct.
Although there have been 2 recent reviews of the literature of
functional lung imaging in thoracic radiotherapy, these have
focused more broadly on the application of different imaging types
in clinical practice by looking at the integration of functional imag-
ing into radiotherapy planning and the benefit of reducing the dose
to normal lung [12,13]. Our paper focuses on the technical details
of the CTVI validation methodology; an understanding of this is
crucial to define the utility and limitations of different approaches
in assessing different kinds of pulmonary pathology, and standard-
ization of these technical details is essential if we are to move for-
ward and validate the integration of CTVI-based radiotherapy
planning in clinical trials. The CTVI literature concentrates on the
assessment of regional ventilation, but we also review alternative
imaging approaches and discuss whether CTVI is the most appro-
priate modality for imaging pulmonary physiology in thoracic
radiotherapy patients with pulmonary disease other than obstruc-
tive diseases, such as pulmonary vascular and interstitial lung
disease.
Hence our purpose is twofold: (1) to summarize, and assess the
quality of the validation literature for CTVI using the methodology
of a systematic review and (2) to compare alternative imaging
modalities for assessing regional pulmonary pathology, which
may provide guidance as to the use of appropriate imaging for
future studies in thoracic radiotherapy patients.Methods
The systematic review of the CTVI validation literature review
was performed following the preferred reporting items for system-
atic reviews and meta-analyses (PRISMA)-statement reporting
standard [14]. This consensus statement defines the process and
items deemed essential for transparent reporting of a systematic
review. Table 1 presents our research questions in the patients,
intervention, comparison, outcome, study design (PICOS)
approach.Search strategy
Between the 5th and 7th of September 2017 searches were per-
formed on PUBMED and EMBASE using the search term ‘‘CT Venti-
lation”. Further studies were identified by handsearching of
references and identification of studies that could possibly meet
the selection criteria, as well as by direct input from the authors
of the study.
These references were exported to the Systematic Review Data
Repository (SRDR), an online and freely available resource pro-
vided by the US National Institute of Health (NIH) for the manage-
ment of data in systematic reviews, which is available at www.
srdr.ahrq.gov. The SRDR software was used to exclude duplicate
studies and to assess if studies met selection criteria.Paper selection and data extraction
Two reviewers (FH and JK) reviewed the papers independently
to assess if they met study selection criteria. Study details were
collected and are available in the Systematic Review Data Reposi-
tory (www.srdr.ahrq.gov). If there was discordance in the assess-
ment a third reviewer (DR) reviewed the papers. Paper quality
was assessed using the STARD Quality Dimensions for Diagnostic
Tests by FH and JK [15] and the QUADAS-2 [16]. The process of
study selection and details of studies excluded at each step are out-
lined in Fig. 1.
The following data were extracted from each paper:
1. Type of CT protocol (4DCT or breath hold)
2. Type of comparative or ‘‘reference” ventilation imaging modal-
ity (Ventilation PET or SPECT, Xenon CT or Hyperpolarized gas
MRI)
3. Use of breathing guidance for each scan, for example audiovi-
sual (AV) biofeedback or ventilation under anaesthesia in ani-
mal studies)
4. Details of comparison metric used (Spearman’s correlations,
Dice similarity coefficient, or linear correlation of CoV/lobar
function values etc.)
Fig. 1. Characteristics of papers. This table provides an overview of study cohort and describes the gold standard correlation. Other details of the metrics such as post-
processing and the methodology for comparison is described, whether this be voxel-based (Voxel) or based on a functional unit of lung (such as the lobe or whole lung)
[Lobar, Regional and Whole], and whether respiratory defects (Defect) or high functioning lung (High) was evaluated. In this table the strongest average correlation reported
in that paper is recorded for any type of correlation. Grey boxes indicate characteristics which are not applicable to these papers. Abbreviations: Normal Comparator (NC),
Deformable Image Registration (DIR), Dice Similarity Coefficients (DSC) and linear regression (LR) methods, smoothing (Smooth), mass density corrected metric (MDC),
Spearman Rank Correlation (SPC), Dice Similarity Coefficient (DSC), Linear Regression (LR) are also described.
F. Hegi-Johnson et al. / Radiotherapy and Oncology 137 (2019) 175–185 1775. Details of CTVI algorithmsby:DIR type (if any),Whethermasking
was used, What functional quantification metric(s) were used
(e.g. DIR-Jac, DIR-HU, other hybrid methods that combine the
Jacobian and HU changes, DIR-Hy, as well as the use of various
model-based scaling factors as described in the Results section).
6. Image smoothing/filtering used at any stage in the process (for
example, pre-smoothing of the input 4DCT phase images, or
application of a box filter to pixel values in the output CTVI).
7. Details of the DIR assessment (if any), based on the techniques
recommended by the report of the AAPM Task Group 132. This
includes visual inspection of deformed images and/or motion
fields, evaluation of target registration error (TRE) using expert
selected anatomic landmarks, or determination of the presence
of any negative values of the DIR motion field Jacobian determi-
nant, which indicates non-physical motion.
Selection criteria
Studies were accepted if they
(1) Quantitatively correlated CTVI against an accepted clinical
reference for measuring clinical function (either clinical/ex-
perimental imaging or spirometry)
(2) Generated CTVI from either 4DCT or BHCT without the use of
a radioactive, iodinated or other imaging contrast other than
air.
(3) Reported in the English language.
(4) Published in a peer-reviewed journal between the years
2000 and 2018. The start date was chosen as the year 2000
since the review by Simon et al. is often taken as an originat-
ing paper for the DIR-HU formulation [17].
(5) Intra-patient imaging/spirometry measurements were
acquired within a reasonable timeframe (e.g. <3 months)
without pulmonary intervention (namely, surgical resection
or radiation therapy).
(6) Report detailed methodology for generation of CTVI images
for example CT post-processing, image registration method-
ology, and/or other relevant algorithm/acquisition
parameters.Human and animal studies were both acceptable.
Even if meeting the above criteria, studies were rejected which:
(1) Did not have an intrapatient comparison to compare the
standard functional imaging or accepted pulmonary func-
tion tests such as spirometry and other measures of static
lung function against CTVI.
(2) Used PET/CT, SPECT/CT or contrast-enhanced CT as the ven-
tilation imaging test modality (these will be not be classified
as ‘‘CTVI” for the purposes of this paper).
(3) Lacked a statement of statistical significance.
(4) Did not describe, or reference to an article, in sufficient detail
the method of generation of the CTVI scan.
(5) Did not describe, in sufficient detail, the level of spatial
detail used for the cross-modality comparison.
(6) Was not a scientific paper (for example, conference abstract,
patent, book, conference proceeding).
(7) Was not a new investigation (for example, a review or
editorial).
Statistical methods
Given the great heterogeneity across the studies included in our
analysis, which are nearly all single arm and very small a formal
meta-regression was not considered meaningful. However, just
over half of studies presented voxel-based Spearman’s rank corre-
lations, and to facilitate cross comparison of these studies we have
calculated the standard errors and present these results here. All
statistical analyses were performed in Microsoft Excel (Office
2016) and Graphpad Prism 8 (Version 8.02, 2019).
Results
One hundred and forty-two records were identified through
searching of Pubmed and Embase and handsearching. After the
exclusion of 34 duplicate records, the abstracts of 108 records were
reviewed. Twenty-eight records were rejected after abstract
review for not meeting eligibility criteria. The majority of these
were conference abstracts.
178 Is CT Ventilation Imaging the Answer for Assessing Regional Ventilation?Paper selection
Sixty-nine full text records were reviewed, and after detailed
assessment twenty-three full text papers met selection criteria
and were included in the final review (see Fig. 1 in the Supplemen-
tary material for details of the papers selected and eliminated at
each stage). Forty-six records were rejected for (1) failing to
include an intrapatient comparison with an accepted gold standard
(24 records), (2) using contrast-based methods to assess ventila-
tion (5), (3) being conference abstracts not full papers (13 records),
and (4) being review papers with no original data (4 records). Four
papers were reported in animals and 19 papers were reported in
humans. There were fourteen prospective studies. Altogether 579
human subjects were included, averaging 25.2 participants per
study.
Technical aspects of 4DCT ventilation methods
Defining ‘‘normal” ventilation within a diseased lung is chal-
lenging as most assessments of high functioning lung are based
on normalized values. In view of this, it is interesting that only 1
human study included normal subjects [18] and only 5 papers
assess the accuracy of validation of both high and low functioning
lungs (labelled as ‘‘High” and ‘‘Defect” in Fig. 2) [19,6,20,21,10].Fig. 2. (a and b): SPC, DSC and LR for DIR-HU (Fig. 3a) and DIR-Jacobian (Fig. 3B) respect
(<0.7–1.0).The majority of papers used deformable image registration
(DIR) based methods for CTVI generation [2,22,23,24,1,19,25,7,18,
20,26,27,5,28,4,9,6,29,10] although some papers evaluated both
DIR and non-DIR based methods [6,10] (see Table 2 for details).
The most common algorithms were DIR-HU and DIR-Jac (16 and
15 papers respectively).
Seventeen out of 23 papers used smoothing, to reduce CT noise
prior to computing HU based CT images. Sixteen papers used
masking to reduce the impact of image artefacts from DTPA depo-
sition upon image assessment. Twelve authors using DIR-Jac met-
rics included some form of mass density correction to correct for
respiratory induced changes in blood mass within the lung. Please
refer to Fig. 1 for an overview of papers and see the discussion for
details of pre and post-processing techniques used in the papers
reviewed.
Diverse methods were used to analyse the relationship between
CTVI and the ‘‘gold-standard”, the commonest being Spearman’s
Rank correlations (SPC), Dice Similarity Coefficients (DSC) and lin-
ear regression (LR) methods. The Spearman r values are defined in
the range [1, 1] and indicate the degree of monotonicity of values
in spatially matched voxels within the whole lung ROI with 1 indi-
cating a perfect positive correlation. The Dice similarity coefficient
(DSC) describes the fractional volume overlap between two regionsively. Correlations are graded as either weak (0–0.3), moderate (<0.3–0.7) or strong
Table 2
(a) Animal studies and (b) human studies: summary of CTVI studies. CTVI generation is defined as non-DIR and DIR based, which includes DIR Jacobian (DIR-Jac), DIR-HU and other hybrid DIR approaches (DIR-Hy). Papers used various
metrics for assessing the strength of correlation, including linear regression (LR), Spearman’s Rank correlations (SPC) and Dice Similarity Coefficients (DSC).
Study author (year) Subjects
No.
Comparative Imaging
Modality
CTVI Generation Type of correlation Highest level of correlation Range of correlation
(a): Animal studies of CT ventilation
Fuld et al. [30] 4 sheep Xenon-CT Change in volume
as assessed by
change in HU
units
Voxel based
LR
LR R2 of 0.76 0.56–0.76
Reinhardt et al. [22] 5 sheep Xenon-CT DIR-Jac Voxel based
LR
LR R2 of 0.80 0.64–0.80
Ding et al. [23] 4 sheep Xenon-CT 2 variants of DIR-
Jac
(SAJ, SACJ) and
DIR-HU
Voxel based
LR
SAJ
r = 0.97
SACJ
r = 0.994
DIR-HU
r = 0.952
0.836–0.97
0.888–0.994
0.893–0.952
Zhang et al. [24] 4 sheep Xenon CT 3 metrics tested:
1. DIR D Vol
2. DIR-Jac
3. DIR-HU
Voxel based SPC D Vol
0.61
Jacobian
0.61
HU
0.42
0.29–0.61
0.31–0.61
0.17–0.42
(b): Human studies of CT ventilation
Guerrero 2005 [2] 22 Measured tidal volume on
CT
DIR-HU LR of lung volumes and tidal volumes. DIR HU LR r = 0.985 LR r ranged from 0.982 to 0.985
Guerrero [1] 3 lung cancer RT
patients
Measured tidal volume on
CT
DIR-HU Whole lung based DIR-HU LR r = 0.985 NR
Castillo et al. [19] 7 thoracic
oncology
patients
DTPA-SPECT DIR-HU DIR-Jac Voxel based DSC Highest average DSC was for 0–
20% voxels
DSC ranged from 0.2 to 0.35
Murphy et al. [25] 216 patients
with COPD
Spirometry DIR-HU Whole lung and lobar assessment
LR of GOLD stage FEV1 and FEV1/FVC
Median r value of 0.87 for
whole lung
0.85–0.91
Matthew et al. [31] 11 lung cancer
patients
3HE hyperpolarized MRI DIR-HU DSC to compare ventilated volume
(VV) in both whole lung and lung
ipsilateral to and contralateral to
cancer
DSC
0.89 ± 0.01
0.69–0.95
Choi et al. [18] 30 asthma
patients, 14
control subjects
PFT’s comparison of Total
Lung Capacity (TLC) and
Air volume (AV) at exhale
DIR-Jac derived
from breath-hold
CT
Global lung function LR R = 0.87 for Total lung volume in
severe asthmatics
r = 0.78–0.87
Yamamoto et al. [20] 9 patients with
thoracic cancer.
DTPA-SPECT DIR-Jac Voxel based SPC, DSC for segmented
low-functional lung regions
Best Spearman’s rank 0.80
Best DSC 0.8
Average 0.69 ± 0.26
0.71±
Kipritidis et al. [6] 12 lung cancer
patients
PET-Galligas DIR-HU and DIR-
Jac with and
without density
scaling
Voxel based SPC Density-scaled HU
Spearman’sr = 0.28 ± 0.13 and
DSC (lowest 20%) = 0.52 ± 0.09
DIR-Jac 0.25 ± 0.17
(continued on next page)
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Table 2 (continued)
Study author (year) Subjects
No.
Comparative Imaging
Modality
CTVI Generation Type of correlation Highest level of correlation Range of correlation
Yamamoto et al. [5] 18 patients- all
with thoracic
cancer
DTPA-SPECT
and PFT’s (spirometry and
measurement of DLCO)
DIR-HU DIR-Jac Voxel based DSC to quantify overlap
between V4DCT and VSPECT defect
regions
Pearson’s correlation with FEV1 and
FEV1/FVC
DSC for DIR-HU
0.39
Average DSCs were:
DIR-HU 0.39 ± 0.11
DIR-Jac 0.36 ± 0.13
FEV1/FVC strongly correlated with 25% voxel
value (0.73) and strongly negatively correlated
with defective lung (0.63)
Brennan et al. [26] 98 patients with
lung cancer
Spirometry DIR-HU and DIR-
Jac
LR to compare spirometry and CTVI
CoV V20,
and visually defined defects
Correlation coefficient  0.7 for
HU
DIR-HU CoV CC between:
DIR-HU
FEV1 0.72
FEV1/FVC 0.67
DIR-Jac
FEV1 0.40
FEV1/FVC 0.38
King et al. [27] 30 Thoracic
radiotherapy
patients
Tidal volume from 4DCT
and CTVI compared
DIR-Jac
DIR-Hy
Whole lung based Pearson’s
correlation coefficient
TVInt and TVCT was 0.92
(P < .01)
TVJac
and TVCT was 0.97 (P < .01)
Not reported
Eslick et al. [28] 11 lung cancer
patients
PET Galligas DIR-HU Lobar volumes and ventilation
compared with LR
r-Value 0.96 for comparison of
lobar ventilation from CTVI and
PET-Galligas
Average r-value between CTVI analysed lobar
ventilation and lobar volumes was 0.78
Kipritidis et al. [21] 25 lung cancer
patients
PET-Galligas Non-DIR based HU
DIR-HU
DIR-Jac
Voxel based
SPC
CTVI-HU 0.50 Mean ± SD correlation with Galligas PET was r =
(0.50 ± 0.17), (0.42 ± 0.20), and (0.19 ± 0.23) for
the CTVI-HU, DIR-HU, and DIR-Jac methods
Kida et al. [4] 8 thoracic cancer
patients
DTPA SPECT and
Spirometry
DIR-HU and DIR-
Jac
Radiotherapy lung metrics compared
with Pearson’s correlation and LR
0.94 for DIR-HU DIR-HU Pearson’s R = 0.94 and linear
regression = 0.71
DIR-Jac
R = 0.85; slope = 0.5
Kanai et al. [32] 11 lung cancer
patients
Planar Kr images DIR-HU and DIR-
Jac
Voxel based SPC HU 0.875 Mean ± SD: DIR-HU 0.875 ± 0.07
DIR-Jac 0.803 ± 0.114
Tahir et al. [33] 30 patients with
sputum
eosinophilia and
asthma
Hyperpolarized 3He MRI Breath-hold CT at
total lung capacity
and functional
residual capacity
used to assess
change in volume
of lobes
Lobar
Pearson’s correlation of all lobar
regions
0.65 Range of Pearson’s correlations not stated
Vinogradskiy et al. [29] 16 lung cancer
patients
DTPA SPECT and
spirometry
DIR-HU Global lung function
ROC analysis to compare,
4DCT-ventilation-based preop FEV1
vs. SPECT based preop FEV1
0.99 correlation coefficient for
prediction of ventilation
changes after lobectomy using
CTVI
Pneumonectomy: Correlation coefficient 0.80
(0.81 for nuclear medicine-ventilation
And 0.78 for nuclear medicine-perfusion).
Lobectomy:
Correlation coefficient was 0.99 for CTVI
Hegi-Johnson et al. [10] 11 lung cancer
patients
Technegas SPECT CTVI-HU,
DIR-HU and DIR-
Jac
Voxel based Spearman’s Rank and
DSC, lobar based Pearson’s Correlation
and whole lung CoV
Non-defect regions: CTVI HU,
DIR-HU and DIR-Jac mean DSC
of 0.69, 0.68, and 0.54
Defect regions mean DSC were
0.39, 0.33, and 0.44.
Spearman’s r: 0.26, 0.18 and 0.02 for CTVIHU,
DIR-HU and DIR-Jac respectively
Tahir et al. [8] 11 lung cancer
patients
129Xe and 3He MRI DIR-HU, DIR-Jac,
Specific gas
volume change
Spearman’s rank correlations of
different ROI sizes
DIR-HU SPC R = 0.37,
DIR-Jac SPC 0.31,
Specific gas volume 0.34
Voxel-level:
0.1–0.8
ROI 20x20 voxels:
R = 0.2–0.9
Abbreviations: Coefficient of Variance (CoV), forced expiratory volume in 1 s (FEV1), FVC forced vital capacity, D Vol ventilation calculation of ventilation based on change in volume, Region of Interest (ROI).
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regions) and takes a value in the range [0, 1].CTVI metrics
Evaluating the precision of DIR
The majority of papers selected (22 out of 23 papers) used a DIR
based approach to CTVI generation, although several of these also
tested non-DIR based approaches on the same subject group. The
commonest DIR approach was B-spline based with 12 papers using
some variation of B-spline algorithms [1,2,6,8,10,18,21,23,24,25,
27,28]. Just over half of papers (13 out of 23) either discussed
the method used to assess registration accuracy or referenced this
within the text. Target registration errors (TRE) were quantified or
referenced for DIR methods in 11 papers, with the other papers
using visual assessment (2) and semi-automated landmark analy-
sis (1). Most papers reported TRE of <1.5 mm indicating that DIR
was accurate. However, the lack of reporting in 9 of the papers
using a DIR CTVI approach is potentially problematic, as this is crit-
ical for the accurate calculation of regional ventilation. Please see
our supplementary files for details of images registration method-
ology and registration accuracy assessment in individual papers.Comparing ventilation metrics
Eighteen papers evaluated HU based metrics, with all papers
evaluating DIR-HU; within this group, 3 papers evaluated non-
DIR HUmetrics in addition to DIR based approaches. Fifteen papers
evaluated DIR-based Jacobian metrics. For details of the compar-
ison methodology and strength of correlation, please refer to
Fig. 3a and b.
Average ± S.D. linear regression correlation coefficients were
0.73 ± 0.24 and 0.86 ± 0.11 for DIR-Jac and DIR-HU respectively,
and the SPC were 0.45 ± 0.31 and 0.41 ± 0.11 for DIR-Jac and DIR-
HU respectively.
The number of papers consistently reporting on the size of
region of interest (ROI) used in comparison was too small to draw
strong conclusions, although in 2 papers which compared small
ROIs (<1 cm3) vs. large ROIs (4 mm slices of the whole lung fromFig. 3. Overview of typical workflow for a DIR-based CTVI validation study including c
ventilation imaging (right arm). This demonstrates the multiple variables that should be
include details of the DIR methodology (orange boxes), including the metrics used to per
processing (blue boxes) may occur both before or after the CTVI image is generated (pleas
(brown boxes), although DIR-Jac and DIR-HU are the commonest. Common steps in thetop to bottom) the linear regression correlation coefficients were
quite different, being 0.56 ± 0.49 and 0.84 ± 0.16 respectively.Discussion
The primary function of the lung is gas exchange of which ven-
tilation, perfusion and diffusion are fundamental components; oxy-
gen from the air and carbon dioxide excreted by the body and
dissolved in the blood is exchanged across the alveolar membrane.
Even in healthy lungs this process is dynamic, with heterogeneous
ventilation throughout the lung, partly because of mechanical
issues such as the difference in pressure between the top and bot-
tom of the lung, and partly because of rapid changes within the pul-
monary vasculature. In patients with lung disease the local
pathology can differ according to the underlying aetiology. Patients
with severe COPD have obstructive pulmonary function test results
and have large areas of the lung that are not ventilated due to flow
limitation/hyperinflation. In patients with emphysema, spirometry
can be remarkably normal, but diffusion is impaired due to destruc-
tion of alveoli. In asthmatic patients, obstruction can be reversible,
but in severe cases it can be irreversible as well. In pulmonary vas-
cular disease, ventilation may be adequate, but the ventilated lung
is inadequately perfused. Finally, in interstitial lung disease, there is
a restrictive pulmonary function, with both ventilation (although in
a restrictive pattern: i.e. normal or increased FEV1/FVC ratio, but
decreased tidal volume, decreased TLC and FVC) and perfusion pre-
sent in the diseased areas of lung, but gas diffusionmay be impaired
depending on the cause of the restrictive pattern (interstitial lung
disease vs. thoracic wall pathology). To make matters more compli-
cated, patterns can overlap with multiple pathologies present in
patients with severe lung disease.
All of the papers included in this review investigate the use of
imaging technologies to define regional ventilation, although some
have included perfusion scans as well [6,10]. Given the dependence
of gas exchange on perfusion, ventilation and diffusion, can imag-
ing technologies which do not assess perfusion or diffusion provide
useful information? We know from previous studies that perfusion
scans can demonstrate changes after radiotherapy, and there is
some evidence that they may strongly correlate with pulmonaryommon steps for CTVI generation (left arm) and validation against contrast-based
considered when reporting and assessing CTVI validation studies. These variables
form DIR and the details of the respiratory phases included in the registration. Post-
e see the text for details of this). Finally, the metrics that may be applied are diverse
CTVI validation workflow are in the same colour as the CTVI generation pathway.
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focus on ventilation has limited its applicability to patients with
mainly gas exchange problems without an impairment in ventila-
tion. In this review, we have chosen to limit our assessment to
papers focusing on ventilation for two reasons. Firstly, CT scans
are now used as part of the standard workflow in radiotherapy
planning and the assessment of surgical resection candidates. They
are cheap and widely available making CTVI a highly accessible
technology. Secondly, CTVI has rapidly progressed into clinical tri-
als, and we wished to assess the robustness of the literature, which
has focused largely on technical rather than clinical validation
measures.
Defining the ‘‘gold standard”: Alternative Imaging Methods to
Assess Regional Ventilation with hyperpolarized gas MRI and
nuclear imaging.Nuclear medicine assessments of pulmonary function
V/Q SPECT and V/Q SPECT-CT are established modalities for the
assessment of regional pulmonary function. Isotopes in common
use include 99mTc-labelled particulate aerosols such as 99mTc-
diethylenetriamine pentaacetic acid (99mT c-DTPA) or the ultra-
fine carbon-labelled nanoparticle 99mTc-Technegas (Cyclomed-
ica). Subsequently, 99mTc-macroaggregated albumin is
administered and a perfusion scan acquired [36]. V/Q PET-CT using
Gallium-68 (68Ga) has been developed, allowing higher resolution
imaging of radioisotope uptake [37], but is unlikely to be widely
clinically implemented due to the need for a 68Ga-generator within
departments. All these radioisotope techniques suffer to some
extent from issues of clumping in the central airways, although
peripheral airway distribution can be improved using smaller par-
ticles such as Technegas or Galligas, and by careful ventilation of
the patient with deep tidal breathing during radioisotope inhala-
tion to ensure even distribution throughout the lung parenchyma.
Their great advantage is the ability to simultaneously image perfu-
sion, and they have been shown to be sensitive and specific for the
diagnosis of pulmonary emboli, although they are not routinely
used for the diagnosis of other pulmonary pathologies [36].Spirometry based pulmonary function tests (PFT)
Spirometry remains the most common PFT performed in the
assessment of lung cancer patients, but is limited to the assess-
ment of obstructive pulmonary disease (and although it may be
abnormal in restrictive pulmonary pathology, is not diagnostic)
and does not provide information about the function of the lung
parenchyma where gas exchange occurs. Also, spirometry does
not measure hyperinflation in the lung; these areas of hyperin-
flated lung, as represented by the large residual volume (RV) in
patients with severe obstructive COPD do not contribute to gas
exchange. Spirometry is highly dependent on respiratory effort,
and incorrectly performed spirometry may be non-diagnostic. This
introduces great variability into their performance by individual
patients who may have similar pathological profiles within the
lung parenchyma.MRI using hyperpolarized gases and the assessment of regional lung
function
Hyperpolarized gas MRI gives detailed information about both
the lung microstructure and regional ventilation. Both 3He
[38,39] and 129Xe [40,41] have been used to assess regional pul-
monary physiology. Studies with 3He have shown strong correla-
tions to spirometry in patients with a variety of pulmonary
pathologies including COPD and asthma [42,43]. 129Xe diffuses
through the alveolar membrane and into the red blood cells inthe blood stream, producing distinct resonant signal frequencies
in each vascular compartment and has great potential for studying
gas diffusion between the lungs and the blood stream.
Diffusion-weighted 3He and 129Xe MRI can be used to evaluate
the apparent diffusion coefficient (ADC) of lung parenchyma,
which can give highly detailed information about lung microstruc-
ture at the alveolar level. These studies have been shown to corre-
late with early ultrastructural changes seen on MRI.
Hyperpolarized gas MRI static ventilation images show the
regional distribution of inhaled noble gas and have been used by
Tahir et al, who demonstrated moderate to strong correlations
between them and CTVI at the lobar and voxel levels [33,8,44]. In
many respects, hyperpolarized gas MRI provides a level of anatom-
ical and physiological detail that is not yet available in 4DCT. Ini-
tially, implementation was limited by the high cost of 3He but
the maturation of 129Xe MRI has made this into an accessible tech-
nology for future studies.Common elements and limitations in CT ventilation studies
CT acquisition and issues of CT quality
Initial steps towards the development of CTVI occurred in the
early 2000s with the publications of methods to derive information
about regional ventilation from CT datasets [1,30]. The three key
steps in the generation of a DIR-based CTVI image are essentially
identical: (1) acquisition of a respiratory-correlated CT scan, most
commonly 4DCT or sometimes BHCT, (2) application of DIR typi-
cally between the exhale and inhale phase images, and (3) compu-
tation of a ventilation metric either directly on the DIR motion field
(e.g. DIR-Jac) or using the motion field to process changes in HU
values for spatially registered voxels in the inhale and exhale
images (DIR-HU) or both (DIR-Hy).
The first 10 years of development of the CTVI methodology have
been marked by the wide variety of technical processes that have
been explored and are currently in use to generate CTVI images
(see Fig. 3).
The majority of CTVI validation studies have focused on the use
of 4DCT, which involves image reconstruction into 5–10 different
respiratory ‘‘phase bins” based on the synchronous acquisition of
CT projection data and a breathing motion signal [45]. In clinical
human studies, the 4DCT scan is often performed under free-
breathing (FB), which can lead to the well-known problems of ana-
tomic truncation, duplication and blurring artefacts that arise due
to irregular breathing motion, for example, coughing or changes in
breathing period/amplitude during the scan. It has been reported
that up to 90% of clinical 4DCT scans suffer anatomic imaging arte-
facts of magnitude >4 mm [46].
SomeCTVI studieshaveattempted toovercome the issueof irreg-
ular breathing using some form of AV biofeedback to increase the
regularity of breathing [5,28], or using different methods of sorting
the CT by matching bins based on anatomical features rather than
the phase of respiration [20]. CTVI can also be derived from
exhale/inhale image pairs acquired during breath-hold [2,28,18],
although acquiring these images in thoracic cancer patients with
impaired respiratory function can be challenging. By comparison,
in animal studies the subjects are anaesthetized during the 4DCT
scan, resulting in highly regular breathing motion with minimal
4DCT reconstruction artefacts. Other interesting methods to reduce
image noise included using anatomic sorting rather than phase
based sorting to reduce artefacts within 4DCT images [20].
Pre/post-processing of images
The majority of studies in this review applied smoothing to
either the input 4DCT images, the resulting CTVIs, the correspond-
ing contrast-based ventilation images, or some combination of
these. Various smoothing techniques were applied including
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within the raw 4DCT [1,4,10,25,24,19,25,18,26,28,21,32,29], or
CTVI image [31,32,10] or by applying smoothing functions during
the generation of the CTVI image [18,20]. There is some evidence
to suggest that the method of filtering can affect the strength of
the correlation coefficients, although this appears to plateau at a
median filter radius of 3  3  3 voxels [8].Ventilation metric
Ventilation metrics may be classified into DIR-based vs. non-
DIR based algorithms. The commonest DIR metrics evaluate
vowel-wise HU changes between spatially aligned images (DIR-
HU) [1,2] or regional volume changes based on the Jacobian deter-
minant of the DIR motion field (DIR-Jac) [22]. A small number of
‘‘hybrid” metrics have also been investigated, which may combine
information about HU and volume changes to model lung elasticity
as an alternate surrogate for lung function (DIR-Hy) [8,27]. Non-
DIR HU metrics (nonDIR-HU) have been found to be potentially
robust against 4DCT motion artefacts, and use average HU values
to model blood–gas exchange in the lung parenchyma [10,21].
Physiological ventilation is a process of blood–gas exchange with
diffusion of oxygen and carbon dioxide across the alveolar mem-
brane. The HU values of a voxel reflect the air and tissue content
of that particular part of the lung parenchyma, and in the
nonDIR-HU model this is used as a surrogate for the capacity of
blood–gas exchange at each voxel. As this approach relies on the
average intensity projection of the 4DCT, it is closer to the average
scans acquired in nuclear medicine imaging, and also reduces the
impact of respiratory artefacts on CTVI image quality.Statistical methods used for cross-modality comparisons
A number of methods have been used to analyse the accuracy of
CTVI with respect to paired contrast-based comparator ventilation
scans, including the SPC, DSC and Linear regression methods.
The size of the region of interest (ROI), relative to the pixel or
voxel dimensions, has been seen to affect the strength of cross-
modality correlation values obtained [8], with stronger correla-
tions seen for larger ROIs. It is thought that averaging out ventila-
tion values over larger ROIs can mitigate errors created by mis-
registration between the CTVI and contrast-based comparator
scans, errors in the DIR process or imaging artefacts in either the
4DCT or contrast-based comparator scans [10,30]. This is particu-
larly relevant in studies that have used clinically acquired imaging
and hence, although voxel based comparisons are important to
benchmark different CTVI and DIR methodologies, CTVI may be-0.2 0 0.2
Voxel-based S
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Fig. 4. Forest plot illustrating mean ± standard error for studies that present voxel-based
studies that present similar results, and the wide error bars. The size of the icon is propmost robust when defining loco-regional function at larger
anatomical distance scales, such as lung lobes [10,28].
Different semi-automated approaches exist for thresholding
lung ventilation images into high or low-function lung zones; how-
ever, there exists no consensus on which is the best approach.
Since CTVI is amenable to quantitative analysis, a number of CTVI
studies have defined low function lung as referring to those lung
voxels with ventilation values less than the 20th–30th percentile
ventilation for that patient. In contrast, clinical assessment of
nuclear medicine ventilation images is usually based on the visual
analysis of scans by a physician. Relatively little work has been car-
ried out to validate semi-automated thresholding of lung ventila-
tion images against clinical assessment [21]. It is encouraging
that the correlation of functional dose with toxicity outcomes
(e.g. Grade 3 + pneumonitis) may be relatively stable despite dif-
ferent methods for weighting the ventilation values in CTVI [47].Assessing the quality of the literature
CTVI is a promising imaging technology, however the CTVI liter-
ature is hampered by the heterogeneity in the methodology for
CTVI generation, the choice of reference modality and method of
cross-modality comparison and issues of study quality, with only
14 small prospective studies. These issues of study quality and
heterogeneity explain the wide variation in the strength of correla-
tion seen. Indeed, even comparing a single parameter across the lit-
erature is difficult, with SPC varying between SPC were 0.45 ± 0.31
and 0.41 ± 0.11 for DIR-Jac and DIR-HU respectively. The wide
spread in the standard deviations highlights the small numbers
of papers, low patient numbers and the variability in methods of
analysis in this literature. The small sample sizes and variability
in results is well illustrated in Fig. 4, in which we present a Forest
Plot of the voxel-based SPC results.
The use of comparators at the lobar or whole-lung level can
mask gross errors at the voxel level. Most papers using PFTs as
the comparators relied on spirometry [25,18,5,29], and although
it may be argued that spirometry provides an adequate measure
of ventilation and is hence a valid modality for comparison with
CTVI, it is likely to underestimate the impact of pulmonary diseases
that are not adequately reflected by spirometry, such as emphy-
sema and pulmonary vascular disease.
In Table 3, we provide a summary of the key aspects of the CTVI
validation literature. Both DIR and non-DIR CTVI ventilation met-
rics have achieved robust correlations, but particular approaches
may suit different datasets. For example, as they use the average
projection of the 4DCT to generate the CTVI image, non-DIR0.4 0.6 0.8 1
pearman Rank Correlation 
SPC analyses for different ventilation metrics. Note the relatively small number of
ortional to patient numbers.
Table 3
Summary of findings table.
Key findings
Question: Can CTVI defined regional ventilation provide the same information as contrast-based ventilation imaging and pulmonary function tests?
Population: Patients having 4DCT or BHCT, the majority of whom are undergoing radiotherapy planning
Reference standard: contrast-based imaging of regional lung function and/or spirometry
Findings:
 LR (Average ± S.D.): 0.73 ± 0.24 and 0.86 ± 0.11 for DIR-Jac and DIR-HU
 SPC (Average ± S.D.): 0.45 ± 0.31and 0.41 ± 0.11 for DIR-Jac and DIR-HUHeterogeneity in reporting standards reduces the ability to assess statistical significance
Recommendation No of relevant studies Strength
DIR vs. Non-DIR There is insufficient evidence to recommend DIR over non-DIR approaches Only 4 non-DIR studies Moderate
If DIR based CTVI metrics are used the quality of the DIR should be assessed Weak to
moderate
Selection of
metric
There is insufficient evidence to recommend one CTVI metric over another and further head to
head is required.
19 DIR-HU
15 DIR-Jac
Moderate
CT acquisition
and
processing
CTVI based on both 4DCT and BHCT have shown moderate to strong correlations with clinical
gold standards. There is insufficient evidence to guide the use of one method of acquisition
above another.
4 BH studies Moderate
to strong
There is insufficient evidence to support the use of AV biofeedback routinely in the acquisition
of CT images: studies using AV biofeedback have similar strengths of validation compared to
non-AV biofeedback studies
2 AV biofeedback studies Weak
Post-processing such as smoothing and masking may influence the quality of the CTVI image,
but there is insufficient evidence to recommend for or against their use
18 papers used post-processing, but
methodology was heterogeneous
Weak
Clinical
Validation
Modality
The majority of validation studies have used 3D-imaging and this should be used for future
validation studies for them to be benchmarked against existing methodologies
19 papers used 3D imaging Moderate
to strong
Standardized criteria for clinical assessment (e.g. GOLD criteria) should be used for validation
modalities to increase the clinical relevance of future validation studies.
5 papers reported validation against
spirometry
Moderate
184 Is CT Ventilation Imaging the Answer for Assessing Regional Ventilation?approaches may be more robust when using clinically acquired
4DCT with significant respiratory artefacts. On the other hand, very
high-quality images may be acquired clinically using BH
approaches. Although, BH was only investigated in 4 human stud-
ies [2,8,25,28] this may help to overcome the quality issues created
by irregular breathing motion. Other strategies, such as AV
biofeedback may also be useful, but there is insufficient informa-
tion in the current literature to advocate it for routine implemen-
tation. Similarly, the heterogeneity in the methodologies used for
post-processing makes it difficult to make recommendations.
This lack of standardization makes it difficult to determine
whether CTVI is robust enough to implement in clinical practice.
To improve the standardization of future validation studies, we
recommend: (1) the use of high quality, prospectively collected
datasets and that, where possible, these should include normal
and disease cohorts (2) documentation of respiratory function of
individual subjects as assessed by pulmonary function tests which
are recognized clinical standards (spirometry or cardio-pulmonary
exercise testing), (3) incorporation of high quality ventilation
imaging as a comparator, (4) report on detailed methodology for
their CTVI imaging, including the details of CT image acquisition,
use of post-processing techniques such as smoothing, masking,
methodology of DIR and an assessment of its accuracy and (5)
report on the strength of validation across both high functioning
and low functioning lungs using a cohort of standardized statistical
assessments. We would suggest that these tests should include
voxel-based assessments using the SPC and DSC as a minimum
to allow new modalities to be benchmarked against existing stud-
ies as well as more clinically relevant regional volumes. We would
also encourage the investigation of other comparative methodolo-
gies. For example, although outside of this review, it would be
powerful to compare CTVI defined regional ventilation with
histopathological specimens and this could facilitate the develop-
ment of imaging surrogates for different types of COPD, increasing
the non-invasive options to diagnose these diseases.
Finally, given the complexity of pulmonary pathology found in
thoracic oncology patients, it is possible that CTVI may be most
useful in patients who are affected by obstructive lung diseases
such as COPD, but alternative imaging modalities may be required
in other patients. For example, hyperpolarized dissolved-phase129Xe MRI may be particularly useful in patients with interstitial
lung disease [48], and V/Q SPECT and PET in patients with pul-
monary vascular pathology.
Judgement on the quality of the CTVI validation literature will
ultimately be determined by the outcome of prospective clinical
studies investigating CTVI implementation in radiotherapy
patients (NCT02528942, NCT02308709, NCT02843568) [49,47].
The publication of the VAMPIRE challenge and ongoing CT ventila-
tion imaging evaluation (CTVIE) challenge (https://www.aapm.org/
GrandChallenge/CTVIE/), which uses a range of clinical imaging
datasets to compare DIR and CTVI methodologies will also provide
new insights into the variabilities and uncertainties associated
with this technology [50].
CTVI has shown moderate to strong voxel-based correlations in
most human studies. However, CTVI is being increasingly incorpo-
rated into the clinical workflow of thoracic radiotherapy and is
undergoing clinical validation. Our results show that further
refinement and standardization of CTVI methodology will enable
better comparative studies and a more robust application of this
technology in clinical practice. CTVI appears to be of relevance in
radiotherapy planning, particularly in patients whose main pul-
monary impairment is not a gas exchange problem, and awaits
clinical validation in prospective clinical trials.
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